Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

NCT00072358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

291

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: anti-GD2 murine IgG3 monoclonal antibody 3F8
BIOLOGICAL: anti-GD2 murine IgG3 monoclonal antibody 3F8

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]